Dr Morelli is Senior Researcher in Clinical Pathology at the University of Calabria. In 1998, she graduated with honors in Pharmaceutical Chemistry and Technologies at the University of Calabria, Cosenza, Italy. In 2003, she specialized in Clinical Pathology, after a 4 years (1999-2003) training period at the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA (USA), hosted at the laboratory of Prof. Eva Surmacz. In 2006, she completed her PhD in “Cellular biochemistry and drugs activity in oncology”. She conducted her post-doc experience in the molecular oncology field, improving her expertise in pre-clinical experimentation at the Department of Pharmacy and Health and Nutritional Sciences at the University of Calabria, where she now works as a researcher. Her research interests have always been focused on the growth factors and endocrine pathways, both in breast solid tumors and metastases. Since 2007, Dr. Morelli established interdisciplinary collaborations with Prof. Luigi Pasqua and Prof. Antonella Leggio, by studying the biological effects of anti-cancer strategies based on the use of nanostructured materials, designed as potential platforms for targeted drug therapy. In 2014 they co-founded NanoSiliCal Devices(www.nanosilicaldevices.com), a spin-off company of the University of Calabria, where Dr Morelli in managing consultant.